Ridgeline is entering FIH clinical trials to advance a transformative once-daily pill that restores muscle strength and function in all aging adults.
Privately Funded Company
Company HQ State:
Company HQ Country:
Main Therapeutic Focus:
Lead Product in Development:
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):